相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes
Tommaso Gori et al.
EuroIntervention (2015)
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design
Pier Woudstra et al.
AMERICAN HEART JOURNAL (2014)
Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance Implications for the Management of Incomplete Stent Apposition
Nicolas Foin et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold
Jens Wiebe et al.
CLINICAL RESEARCH IN CARDIOLOGY (2014)
Bioresorbable scaffolds: rationale, current status, challenges, and future
Javaid Iqbal et al.
EUROPEAN HEART JOURNAL (2014)
Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'
Viktor Kocka et al.
EUROPEAN HEART JOURNAL (2014)
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study
Roberto Diletti et al.
EUROPEAN HEART JOURNAL (2014)
Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis
Alfonso Ielasi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation 6-and 12-Month Clinical and Multimodality Imaging Results
Stefan Verheye et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
The Absorb Bioresorbable Vascular Scaffold in Coronary Bifurcations
Vladimir Dzavik et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of De Novo Lesions in the Superficial Femoral Artery The GAIA Study
Martin Werner et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Effect of the Endothelial Shear Stress Patterns on Neointimal Proliferation Following Drug-Eluting Bioresorbable Vascular Scaffold Implantation An Optical Coherence Tomography Study
Christos V. Bourantas et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Patrick W. Serruys et al.
EUROINTERVENTION (2014)
Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)
Cihan Simsek et al.
EUROINTERVENTION (2014)
Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease
Yoshinobu Onuma et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model
Vasim Farooq et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomized, Noninferiority Trial
Patrick W. Serruys et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Michael Haude et al.
LANCET (2013)
ABSORB II randomized controlled trial. A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design
Roberto Diletti et al.
AMERICAN HEART JOURNAL (2012)
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?
Salvatore Brugaletta et al.
ATHEROSCLEROSIS (2012)
Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents Igaki-Tamai Stents
Soji Nishio et al.
CIRCULATION (2012)
First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold A Multi-Imaging Modality Study
John A. Ormiston et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy
Jun Pu et al.
EUROPEAN HEART JOURNAL (2012)
Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives
Salvatore Brugaletta et al.
EXPERT REVIEW OF MEDICAL DEVICES (2012)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini et al.
LANCET (2012)
Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study
Eric Durand et al.
EUROINTERVENTION (2012)
Interaction between a high purity magnesium surface and PCL and PLA coatings during dynamic degradation
Ying Chen et al.
BIOMEDICAL MATERIALS (2011)
Comparison of In Vivo Acute Stent Recoil Between the Bioresorbable Everolimus-Eluting Coronary Scaffolds (Revision 1.0 and 1.1) and the Metallic Everolimus-Eluting Stent
Yoshinobu Onuma et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2011)
Bioresorbable Scaffold The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization?
Yosinobu Onuma et al.
CIRCULATION (2011)
The Pathology of Neoatherosclerosis in Human Coronary Implants Bare-Metal and Drug-Eluting Stents
Gaku Nakazawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA
Nico Bruining et al.
EuroIntervention (2011)
Vascular Restoration Therapy: the fourth revolution in interventional cardiology and the ultimate “Rosy” prophecy
Joanna Wykrzykowska et al.
EuroIntervention (2011)
A.R.T.: concept of a bioresorbable stent without drug elution
Antoine Lafont et al.
EuroIntervention (2011)
OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings
Robert Cottone et al.
EuroIntervention (2011)
Novel fully bioabsorbable salicylate-based sirolimus-eluting stent
Refat Jabara et al.
EuroIntervention (2011)
Design principles and performance of bioresorbable polymeric coronary scaffolds
James Oberhauser et al.
EuroIntervention (2011)
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Six-Month Clinical and Imaging Outcomes
Patrick W. Serruys et al.
CIRCULATION (2010)
Bioabsorbable Coronary Stents
John A. Ormiston et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries
Ron Waksman et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys et al.
LANCET (2009)
Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating
Refat Jabara et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2008)
Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque Morphology
Shuzou Tanimoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston et al.
LANCET (2008)
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial
Raimund Erbel et al.
LANCET (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
A Colombo et al.
CIRCULATION (2003)
Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
E Grube et al.
CIRCULATION (2003)
Exercise-induced coronary artery vasodilation is not impaired by stent placement
W Maier et al.
CIRCULATION (2002)
Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial
F Kiemeneij et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)